Study of Tumor Associated Transplantation Antigens in Mice
Author Information
Author(s): M.F.A. Woodruff, J.D. Ansell, B.A. Hodson, H.S. Micklem
Primary Institution: Medical Research Council Clinical and Population Cytogenetics Unit, University of Edinburgh
Hypothesis
Do different clones from the same tumor express distinct tumor-associated transplantation antigens (TATA)?
Conclusion
The study found that clones from the same tumor have strong TATA but show no cross-reactivity.
Supporting Evidence
- Each clone from the tumor was found to possess strong TATA.
- There was no demonstrable cross-reactivity between the A and B clones.
- Immunization with one clone altered the clonal composition of tumors produced by inoculating a mixture of clones.
Takeaway
The researchers looked at how different parts of a tumor can trick the immune system, and they found that even if two parts come from the same tumor, they can act very differently.
Methodology
Mice were immunized with irradiated tumor cells and then challenged with viable cells to assess TATA.
Potential Biases
Potential selection bias due to the immunogenicity of clones affecting the results.
Limitations
The study may not account for the presence of non-transformed host cells affecting the results.
Participant Demographics
Female backcross CBA mice were used in the experiments.
Want to read the original?
Access the complete publication on the publisher's website